Anhui Provincial Cancer Hospital

This study is testing whether adding a new two-in-one immunotherapy drug (QL1706) to standard chemotherapy works better than chemotherapy alone for people with advanced non-small cell lung cancer. It is for patients whose cancer has started growing again after their first treatme…

This study is testing a new combination treatment for people newly diagnosed with extensive-stage small cell lung cancer, a fast-growing and aggressive form of the disease. It combines an immunotherapy drug (tislelizumab) with standard chemotherapy and radiation therapy. The main…

This study is testing whether a new, non-invasive finger scan can help detect and evaluate two types of heart valve disease: aortic stenosis and aortic regurgitation. Researchers will compare scans from 15 adults with these conditions to scans from healthy people. The goal is to …